OQROGet OQRO Pro
Insider trade

Adc Therapeutics Sa (ADCT)10% owner sold ~$643K

Redmile Group, 10% owner at Adc Therapeutics Sa, sold ~$643K of Adc Therapeutics Sa shares.

~$643K
Approx. value · 169K sh @ $3.80
15.3M
Holds after · shares reported
Traded
Apr 1, 2026
Filed
Apr 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 18, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
  2. Mar 10, 2026Company filing · Form 8-K · ResultsReported its results
  3. Mar 31, 2026Insider · 1 personInsiders: 2 sales (~$1.4M)
  4. Apr 1, 2026 · this disclosureInsider10% owner sold ~$643K of ADCT shares in the open market

What came next

  1. Apr 1, 2026Insider10% owner sold ~$617K of ADCT shares in the open market
  2. Apr 2, 2026Insider · 1 personInsiders: 2 sales (~$16.9M)
  3. May 4, 2026Company filing · Form 8-K · ResultsReported its results
  4. Jun 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 30, 2026, the Board of Directors of ADC Therapeutics SA (the “Company”), with the advice of its independent compensation consultant, approved one-time retention awards (“Awards”) to certain of the Company’s employees, including its named executive officers as set forth below: Name Title Cash Incentive Award RSU Award Ameet Mallik Chief Executive Officer $1,795,500 675,000 Jose Carmona Chief Financial Officer…”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Adc Therapeutics Sa

For Adc Therapeutics Sa, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ADCT page.

Other recent filings by Redmile Group, LLC, 10% owner

The full history of Redmile Group, LLC, 10% owner is on the profile page.

How this filing works

Other disclosures at Adc Therapeutics Sa

Everything OQRO holds on this company is on its ADCT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data